Multi-channel metabolic imaging, with SENSE reconstruction, of hyperpolarized [1-13C] pyruvate in a live rat at 3.0tesla on a clinical MR scanner

GE Healthcare Technologies, Global Applied Sciences Lab, Fremont, CA, United States.
Journal of Magnetic Resonance (Impact Factor: 2.51). 01/2011; 208(1):171-7. DOI: 10.1016/j.jmr.2010.10.007
Source: PubMed


We report metabolic images of (13)C, following injection of a bolus of hyperpolarized [1-(13)C] pyruvate in a live rat. The data were acquired on a clinical scanner, using custom coils for volume transmission and array reception. Proton blocking of all carbon resonators enabled proton anatomic imaging with the system body coil, to allow for registration of anatomic and metabolic images, for which good correlation was achieved, with some anatomic features (kidney and heart) clearly visible in a carbon image, without reference to the corresponding proton image. Parallel imaging with sensitivity encoding was used to increase the spatial resolution in the SI direction of the rat. The signal to noise ratio in was in some instances unexpectedly high in the parallel images; variability of the polarization among different trials, plus partial volume effects, are noted as a possible cause of this.

Download full-text


Available from: Ralph Hurd,
1 Follower
26 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor in humans. Because the phosphatidylinositol-3-kinase (PI3K) signaling pathway is activated in more than 88% of GBM, new drugs which target this pathway, such as the mTOR inhibitor Everolimus, are currently in clinical trials. Early tumor response to molecularly targeted treatments remains challenging to assess non-invasively, because it is often associated with tumor stasis or slower tumor growth. Innovative neuroimaging methods are therefore critically needed to provide metabolic or functional information that is indicative of targeted therapeutic action at early time points during the course of treatment.
    NeuroImage 07/2011; 59(1):193-201. DOI:10.1016/j.neuroimage.2011.07.034 · 6.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rapid volumetric imaging of hyperpolarized (13) C compounds allows the real-time measurement of metabolic activity and can be useful in distinguishing between normal and diseased tissues. This work extends a fast two-dimensional undersampled spiral MRSI sequence to provide volumetric coverage, acquiring a 16 × 16 × 12 matrix with a nominal isotropic resolution of 5 mm in 4.5 s. The rapid acquisition enables a high temporal resolution for dynamic imaging. This dynamic three-dimensional MRSI method was used to investigate hyperpolarized [1-(13) C]pyruvate metabolism modulated by the administration of ethanol in rat liver. A significant increase in the pyruvate to lactate conversion was observed in the liver as a result of the greater availability of NADH (nicotinamide adenine dinucleotide, reduced form) from ethanol metabolism.
    NMR in Biomedicine 08/2012; 25(8):993-9. DOI:10.1002/nbm.2762 · 3.04 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This article describes the basic physics of dissolution dynamic nuclear polarization (dissolution-DNP), and the impact of the resulting highly nonequilibrium spin states, on the physics of magnetic resonance imaging (MRI) detection. The hardware requirements for clinical translation of this technology are also presented. For studies that allow the use of externally administered agents, hyperpolarization offers a way to overcome normal magnetic resonance sensitivity limitations, at least for a brief T(1) -dependent observation window. A 10,000-100,000-fold signal-to-noise advantage provides an avenue for real-time measurement of perfusion, metabolite transport, exchange, and metabolism. The principles behind these measurements, as well as the choice of agent, and progress toward the application of hyperpolarized (13) C metabolic imaging in oncology, cardiology, and neurology are reviewed. J. Magn. Reson. Imaging 2012; 36:1314-1328. © 2012 Wiley Periodicals, Inc.
    Journal of Magnetic Resonance Imaging 12/2012; 36(6):1314-28. DOI:10.1002/jmri.23753 · 3.21 Impact Factor
Show more